Mesalazine-induced lupus syndrome

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Scandinavian journal of rheumatology·2026

Sensitive detection of plasma interferon regulatory factor-5 (IRF5) by solid-phase proximity ligation assay validates IRF5 high and low subgroups in patients with systemic lupus erythematosus.

Scandinavian journal of rheumatology·2025

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

QJM : monthly journal of the Association of Physicians·2024

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.

Scandinavian journal of rheumatology·2022

Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.

Clinical and experimental immunology·2021

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).

Journal of molecular medicine (Berlin, Germany)·2020

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Lupus·2026

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

Lupus·2026

CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.

Lupus·2026

Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.

Lupus·2026

Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.

Lupus·2026

Persistence of antimalarial therapy and its effect on mortality in systemic lupus erythematosus: A population-based longitudinal multistate study.

Lupus·2026

Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial.

JAMA neurology·2026

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Chronic Spontaneous Urticaria with Biochemical C1 Inhibitor Deficiency: A Case Report of Suspected Overlap with Hereditary Angioedema.

Clinical, cosmetic and investigational dermatology·2026

Allergy Diagnosis in India: Current and Future Trends.

Cureus·2026

When Safety Barriers Fail: Paracetamol-Induced Anaphylaxis Under General Anesthesia Despite Multiple Allergy Warnings.

Cureus·2026

Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.

The World Allergy Organization journal·2026

Related Experiment Videos

Mesalazine-induced lupus syndrome

Related Concept Videos

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Sensitive detection of plasma interferon regulatory factor-5 (IRF5) by solid-phase proximity ligation assay validates IRF5 high and low subgroups in patients with systemic lupus erythematosus.

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.

Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.

Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.

Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.

Persistence of antimalarial therapy and its effect on mortality in systemic lupus erythematosus: A population-based longitudinal multistate study.

Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial.

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis.

Chronic Spontaneous Urticaria with Biochemical C1 Inhibitor Deficiency: A Case Report of Suspected Overlap with Hereditary Angioedema.

Allergy Diagnosis in India: Current and Future Trends.

When Safety Barriers Fail: Paracetamol-Induced Anaphylaxis Under General Anesthesia Despite Multiple Allergy Warnings.

Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.

Related Experiment Videos

Mesalazine-induced lupus syndrome

Related Concept Videos

Related Articles